SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-24-007098
Filing Date
2024-05-07
Accepted
2024-05-07 17:30:38
Documents
5
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20240626xpre14a.htm PRE 14A 360148
2 GRAPHIC tmb-20240626xpre14a_bg001.jpg GRAPHIC 132697
3 GRAPHIC tmb-20240626xpre14a_bg002.jpg GRAPHIC 85175
4 GRAPHIC tmb-20240626xpre14a_bg003.jpg GRAPHIC 89808
5 GRAPHIC tmb-20240626xpre14a_bg004.jpg GRAPHIC 29758
  Complete submission text file 0001558370-24-007098.txt   826601
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39619 | Film No.: 24923381
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)